Advertisement

Advertisement

ETON Stock Latest News

Eton Pharmaceuticals Licenses ASN-001 Hemangioma Therapy

Company AnnouncementsEton Pharmaceuticals Licenses ASN-001 Hemangioma Therapy

Eton Pharmaceuticals licenses U.S. rights to ASN-001 from Auson

PremiumThe Fly

Eton Pharmaceuticals licenses U.S. rights to ASN-001 from Auson

17h ago

Eton Pharmaceuticals Promotes Radosavljevic to Chief Operating Officer

PremiumCompany Announcements

Eton Pharmaceuticals Promotes Radosavljevic to Chief Operating Officer

2d ago

Eton Seeks Expanded KHINDIVI Label for Pediatric Use

PremiumCompany Announcements

Eton Seeks Expanded KHINDIVI Label for Pediatric Use

8d ago

Eton reports results from new formulation of Khindivi study

PremiumThe Fly

Eton reports results from new formulation of Khindivi study

8d ago

Eton Pharmaceuticals price target raised to $62 from $40 at Craig-Hallum

PremiumThe FlyEton Pharmaceuticals price target raised to $62 from $40 at Craig-Hallum

9d ago

Apple upgraded, Brinker initiated: Wall Street’s top analyst calls

The Fly

Apple upgraded, Brinker initiated: Wall Street’s top analyst calls

20d ago

Eton Pharmaceuticals initiated with a Buy at Canaccord

The Fly

Eton Pharmaceuticals initiated with a Buy at Canaccord

20d ago

Eton Pharmaceuticals initiated with a Buy at Canaccord

PremiumThe Fly

Eton Pharmaceuticals initiated with a Buy at Canaccord

20d ago

Eton Shareholders Back Board Nominees and Auditor Selection

PremiumCompany Announcements

Eton Shareholders Back Board Nominees and Auditor Selection

2M ago

Eton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target

PremiumRatings

Eton Pharmaceuticals: Buy Rating Reiterated as Strategic IMPAVIDO Deal Supports Asset-Light Growth and Unchanged $57 Price Target

3M ago

Eton Pharmaceuticals Signals Strong Momentum in Earnings Call

PremiumCompany Announcements

Eton Pharmaceuticals Signals Strong Momentum in Earnings Call

3M ago

Eton Pharmaceuticals Secures U.S. Rights to IMPAVIDO

PremiumCompany AnnouncementsEton Pharmaceuticals Secures U.S. Rights to IMPAVIDO

3M ago

Eton Pharmaceuticals enters supply, distribution agreement for Impavido

The Fly

Eton Pharmaceuticals enters supply, distribution agreement for Impavido

3M ago

Eton Pharmaceuticals Signals Strong Momentum In Earnings

Company Announcements

Eton Pharmaceuticals Signals Strong Momentum In Earnings

3M ago

Eton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright

PremiumThe Fly

Eton Pharmaceuticals price target raised to $57 from $52 at H.C. Wainwright

3M ago

ETON Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

ETON Earnings Report this Week: Is It a Buy, Ahead of Earnings?

3M ago

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

PremiumCompany Announcements

Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

3M ago

Eton Pharmaceuticals announces relaunch of Hemangeol

PremiumThe Fly

Eton Pharmaceuticals announces relaunch of Hemangeol

3M ago

Eton Starts Pilot Trial of ET-700 for Wilson Disease

PremiumCompany AnnouncementsEton Starts Pilot Trial of ET-700 for Wilson Disease

3M ago

Eton Pharmaceuticals says first patient dosed in study of ET-700

The Fly

Eton Pharmaceuticals says first patient dosed in study of ET-700

3M ago

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

Company Announcements

Eton Pharmaceuticals Announces New Chief Financial Officer Appointment

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >